Second-born twins are at significantly greater risk for serious perinatal morbidity than first-born twins at all gestational ages, according to the results of a retrospective cohort study conducted in Nova Scotia. And the higher risk prevails regardless of presentation, chorionicity, or infant sex.
Second-born twins are at significantly greater risk for serious perinatal morbidity than first-born twins at all gestational ages, according to the results of a retrospective cohort study conducted in Nova Scotia. And the higher risk prevails regardless of presentation, chorionicity, or infant sex.
Researchers studied approximately 1,500 twin pairs and found that the relative risk for second-born versus first-born twins for composite adverse outcomes was 1.62 (95% CI; 1.38–1.9). Factors that increased the risk included planned vaginal delivery, birthweight discordance, and prolonged interdelivery interval.
While term second-borns suffered less morbidity when delivered via elective cesarean versus the vaginal route, researchers calculated that it would take approximately 33 planned cesarean births to prevent one composite adverse outcome. Perinatal morbidity for second-born twins born at 37 weeks' gestation or later most often entailed asphyxia, while those born earlier most often suffered from respiratory distress syndrome.
Link between prenatal air pollution and reduced lung function in offspring reported
July 25th 2024Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Read More
Cut costs observed from out-of-home care in children with prenatal substance exposure
July 24th 2024A recent study reveals that while children exposed to maternal substance use face higher hospital costs up to age 20 years, out-of-home care significantly mitigates this financial burden.
Read More
Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
Read More
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Read More